Oncology Peer Review On-The-Go: Molecular Profiling Practices in Pancreatic Adenocarcinoma
CancerNetwork® dissects an article from the journal ONCOLOGY® focusing on academic and community molecular profiling practices for patients with pancreatic adenocarcinoma.
In this week’s “Oncology Peer Review On-The-Go,” we discuss an article from the May issue of the journal ONCOLOGY® titled Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic vs Community Physicians. CancerNetwork® spoke with Christine Chung, DO, from the HCA Swedish Medical Center in Englewood, Colorado, about the molecular profiling patterns she and her colleagues observed in this retrospective review. The authors found that both academic and community physicians ordered profiling about 50% of the time, which was contrary to previous reports that suggest academic centers perform molecular profiling more often.
The perspective for this article comes from Roman Groisberg, MD, a medical oncologist and director of the Sarcoma Medical Oncology Program at the Rutgers Cancer Institute in New Brunswick, New Jersey. Groisberg discussed the role of profiling in pancreatic adenocarcinoma, his thoughts on the retrospective review, and the future of profiling for this cohort of patients.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
FDA Clears Chromogranin A Immunoassay in Gastroenteropancreatic NETs
September 28th 2023Clearance of an automated immunoassay allows practices to measure chromogranin A concentration in human serum, thereby tracking disease progression in those with gastroenteropancreatic neuroendocrine tumors.
Oncology Peer Review On-The-Go: Barriers to Pancreatic Cancer Clinical Trial Enrollment
November 11th 2020The latest installment of “Oncology Peer Review On-The-Go” dissects original research published in the journal ONCOLOGY regarding potential barriers to clinical trial enrollment for patients with pancreatic cancer.
